Shaaban A Mousa Selected Research

sauvagine

6/2022

Superior control of inflammatory pain by corticotropin-releasing factor receptor 1 via opioid peptides in distinct pain-relevant brain areas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shaaban A Mousa Research Topics

Disease

45	Pain (Aches) 06/2022 - 05/2002
32	Inflammation (Inflammations) 06/2022 - 05/2002
10	Hyperalgesia 06/2020 - 12/2004
6	Heart Failure 01/2021 - 12/2015
6	Neuralgia (Stump Neuralgia) 01/2019 - 02/2007
5	Diabetic Neuropathies (Diabetic Neuropathy) 01/2019 - 04/2013
5	Arthritis (Polyarthritis) 07/2013 - 02/2004
4	Wounds and Injuries (Trauma) 01/2020 - 02/2007
4	Postoperative Pain 01/2014 - 02/2007
3	Hypersensitivity (Allergy) 01/2020 - 10/2014
3	Neoplasms (Cancer) 07/2013 - 03/2008
3	Lung Neoplasms (Lung Cancer) 05/2010 - 01/2010
2	Osteoarthritis 01/2020 - 07/2007
2	Rheumatoid Arthritis 01/2020 - 07/2007
1	Nociceptive Pain 11/2021
1	Joint Diseases (Joint Disease) 01/2020
1	Acute Pain 06/2018
1	Cardio-Renal Syndrome 01/2017
1	Fibrosis (Cirrhosis) 01/2017
1	Visceral Pain 10/2016
1	Sepsis (Septicemia) 02/2014
1	Edema (Dropsy) 01/2014
1	Left Ventricular Dysfunction 01/2014

Drug/Important Bio-Agent (IBA)

40	Opioid Analgesics (Opioids)IBA 11/2021 - 07/2002
21	Opioid Receptors (Opioid Receptor)IBA 01/2019 - 01/2003
18	Opioid Peptides (Opioid Peptide)IBA 06/2022 - 05/2002
11	Freund's AdjuvantIBA 10/2016 - 08/2003
10	LigandsIBA 01/2020 - 05/2002
9	Analgesics (Analgesic Drugs)IBA 01/2014 - 02/2004
9	beta-Endorphin (Endorphin, beta)IBA 01/2010 - 08/2003
8	Morphine (MS Contin)FDA LinkGeneric 06/2018 - 01/2003
6	Naloxone (Narcan)FDA LinkGeneric 06/2022 - 12/2006
6	Messenger RNA (mRNA)IBA 06/2020 - 05/2006
6	mu Opioid Receptors (mu Opioid Receptor)IBA 12/2017 - 02/2004
6	ChemokinesIBA 01/2014 - 12/2004
6	Methionine EnkephalinIBA 08/2013 - 08/2003
5	Corticotropin-Releasing HormoneIBA 06/2022 - 12/2003
5	EnzymesIBA 06/2020 - 01/2010
4	Corticotropin-Releasing Hormone Receptors (Corticotropin Releasing-Hormone Receptor)IBA 06/2022 - 12/2003
4	Proteins (Proteins, Gene)FDA Link 06/2020 - 09/2013
4	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 08/2016 - 02/2007
4	Capsaicin (Zostrix)FDA Link 10/2014 - 06/2006
4	Nerve Growth Factor (NGF)IBA 07/2013 - 02/2007
3	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 01/2020 - 01/2016
3	14-O-methylmorphine-6-O-sulfateIBA 06/2018 - 08/2013
3	GTP-Binding Proteins (G-Protein)IBA 12/2017 - 02/2004
3	delta Opioid Receptors (delta Opioid Receptor)IBA 02/2016 - 07/2007
3	Peptides (Polypeptides)IBA 12/2015 - 08/2013
3	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2014 - 07/2002
3	Fentanyl (Sublimaze)FDA LinkGeneric 08/2013 - 07/2007
2	Narcotic Antagonists (Opioid Antagonists)IBA 06/2022 - 12/2007
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 11/2021 - 01/2020
2	AldosteroneIBA 06/2020 - 01/2020
2	Cytochrome P-450 CYP11B2 (CYP11B2)IBA 06/2020 - 01/2020
2	CytokinesIBA 01/2020 - 01/2014
2	MineralocorticoidsIBA 01/2019 - 01/2018
2	GlucocorticoidsIBA 01/2019 - 01/2018
2	Calcitonin Gene-Related PeptideIBA 01/2019 - 01/2016
2	Formaldehyde (Formol)FDA Link 06/2018 - 12/2016
2	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2018 - 12/2016
2	Caspase 3 (Caspase-3)IBA 01/2017 - 01/2017
2	Cytochromes c (Cytochrome c)IBA 01/2017 - 01/2017
2	kappa Opioid Receptors (kappa Opioid Receptor)IBA 12/2015 - 08/2003
2	Blood Glucose (Blood Sugar)IBA 10/2014 - 07/2013
2	Insulin (Novolin)FDA Link 10/2014 - 07/2013
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2014 - 09/2013
2	EndorphinsIBA 08/2013 - 11/2010
2	EnkephalinsIBA 06/2012 - 05/2010
2	Ala(2)-MePhe(4)-Gly(5)- Enkephalin (DAGO)IBA 06/2012 - 02/2004
2	Carboxypeptidase H (Carboxypeptidase E)IBA 05/2010 - 01/2010
2	Dynorphins (Dynorphin)IBA 01/2010 - 08/2003
1	sauvagineIBA 06/2022
1	CRF receptor type 1IBA 06/2022
1	2- methyl- 4- (N- propyl- N- cycloproanemethylamino)- 5- chloro- 6- (2,4,6- trichloranilino)pyrimidineIBA 06/2022
1	Naltrexone (ReVia)FDA LinkGeneric 01/2021
1	ProstaglandinsIBA 01/2020
1	Mineralocorticoid Receptor AntagonistsIBA 01/2020
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2018
1	bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA 01/2017
1	GlycogenIBA 01/2017
1	LipidsIBA 01/2017
1	CaspasesIBA 01/2017
1	Dexamethasone (Maxidex)FDA LinkGeneric 12/2016
1	morphine-6-O-sulfateIBA 10/2016
1	Acetic Acid (Vinegar)FDA LinkGeneric 10/2016
1	CalciumIBA 02/2016
1	preproenkephalinIBA 12/2015
1	Streptozocin (Streptozotocin)FDA Link 10/2014
1	Toll-Like Receptors (Toll-Like Receptor)IBA 02/2014
1	Amantadine (Aman)FDA LinkGeneric 01/2014
1	Remifentanil (Ultiva)FDA Link 01/2014
1	N-Methylaspartate (NMDA)IBA 01/2014
1	Peroxidase (Myeloperoxidase)IBA 01/2014
1	CatecholaminesIBA 01/2014
1	Ketamine FDA LinkGeneric 01/2014

Therapy/Procedure

6	Analgesia 11/2021 - 07/2002
2	Intravenous Injections 10/2014 - 07/2013
2	Therapeutics 04/2013 - 01/2007
1	Electroacupuncture 01/2014
1	Catheters 01/2014